75M.F - Wayland Group Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Wayland Group Corp.

2381 Bristol Circle
Door D Suite 102
Oakville, ON L6H 5S9
Canada
289-288-6274
http://www.waylandgroup.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees68

Key Executives

NameTitlePayExercisedYear Born
Mr. Scott M. LangilleChief Financial OfficerN/AN/A1957
Mr. Matthew McLeodCEO, Pres & DirectorN/AN/AN/A
Dr. James HyssenChief Operating OfficerN/AN/AN/A
Dr. Steven Prescott BennettChief Scientific OfficerN/AN/AN/A
Shawn AlexanderVP of Investor RelationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.

Corporate Governance

Wayland Group Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.